Although we believe that the measurement of FOXP3+ TILs and the evaluation of the association of FOXP3+ TILs with breast cancer patient survival are reliable and form a consistent picture with other reports, there are some limitations in this study. This evidence concerns the gene FOXP3 and breast cancer.